RankAlpha logo
Back to Rankings

OPCH

Option Care HealthD
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-11
View Chart
Current thesis
The constructive view is that OPCH still has national scale, acute therapy growth, maintained 2026 adjusted EPS/EBITDA guidance, and added liquidity via an $850M revolver, so the post-earnings selloff may have over-discounted a therapy-mix issue rather than a full-franchise impairment.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Chief Growth Officer Christopher L. Grashoff is departing effective May 8, 2026, increasing scrutiny on commercial execution during a growth slowdown. [#8-K-2026-05-05]
Momentum
5
Value
65
Sentiment
51
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $24.00 · Bull $30.00 · Bear $17.00
Data freshness
Prices
As of 2026-06-11
Fundamentals
As of 2026-06-10 • Vendor: Data Vendor v1
Scores
As of 2026-06-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-06 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-11
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $40.09
Why
Momentum5 · Δ7d +1.8
Value65 · Δ7d -0.1
Sentiment51 · Δ7d -8.6
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
5
34% active weight
Current posture
7d trendFlat
Δ7d
+1.8
Δ21d
+3.2
Value
65
32% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.9
Sentiment
51
33% active weight
Current posture
7d trendSoftening
Δ7d
-8.6
Δ21d
+3.7
Why this grade

Composite grade D. Momentum 5.4 / Value 64.7 / Sentiment 50.6

Fundamentals (TTM)
As of 2026-06-10
Market Cap
$3.36B
Beta
0.84
Shares Out
158.73M
P/E (TTM)
25.5
P/S (TTM)
0.92
P/FCF (TTM)
23.15
Rev YoY
+12.2%
EPS YoY
+1.4%
Gross Margin
+19.4%
Op Margin
+6.0%
Net Debt
$698.59M
Current Ratio
1.56
As of 2026-06-11 • Updated nightlySource: Internal modelMethodology